3 completed. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 3 | Completed 3 |
Follow Cell Medica Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients Autologous WT1 TCR transduced T cells - Myelodysplastic Syndromes (MDS), Acute Myeloid Leukaemia (AML) | Phase 1 / Phase 2 | Completed | Cell Medica Ltd | 3 | 2015-09-01 | 2018-10-02 |
| Safety Study of ADV-specific T-cells in Paediatric Patients Post Allo-HSCT Cytovir-ADV - ADV Infection Post Allo-HSCT | Phase 1 / Phase 2 | Completed | Cell Medica Ltd | 8 | 2012-12-01 | 2018-01-25 |
| WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study WT1 TCR-transduced T cells - Acute Myeloid Leukaemia, Chronic Myeloid Leukaemia | Phase 1 / Phase 2 | Completed | Cell Medica Ltd | 7 | 2012-04-01 | 2018-10-02 |
Leukemia, Myeloid, Acute (2) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Myelodysplastic Syndromes (1)
United Kingdom (3) · Belgium (1) · Germany (1)
Emma Morris, Dr (1) · Emma Morris, MD (1) · Waseem Qasim (1)